Article    Table of Contents                    Full Text of this article    PDF of this article (PDFs free after 6 months)    Summary for Patients    Summary for Patients (PDF)    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Published comments/rapid response letters    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  PubMed Articles in PubMed by Author:    Zhang, S. M.    Ridker, P. M.    Related Articles in PubMed    PubMed Citation    PubMed

ARTICLE

C-Reactive Protein Levels Are Not Associated with Increased Risk for Colorectal Cancer in Women

Shumin M. Zhang, MD, ScD; Julie E. Buring, ScD; I-Min Lee, MBBS, ScD; Nancy R. Cook, ScD; and Paul M. Ridker, MD, MPH

15 March 2005 | Volume 142 Issue 6 | Pages 425-432

Background: Observations that risk for colorectal cancer is elevated in patients with inflammatory bowel disease and that long-term use of anti-inflammatory drugs may reduce colorectal cancer risk have raised the possibility that inflammation may play a role in the development of colorectal cancer. While a recent prospective study observed a positive association between C-reactive protein (CRP), a marker of inflammation, and risk for colon cancer, data testing this hypothesis are sparse.

Objective: To evaluate whether plasma CRP levels predict colorectal cancer risk in women.

Design: Prospective cohort study, with 97% morbidity follow-up and 100% mortality follow-up within the past 2 years.

Setting: Women's Health Study.

Participants: 27 913 apparently healthy women age 45 years or older who had CRP measured at entry into a trial of low-dose aspirin and vitamin E. Maximum length of intervention and follow-up was 10.8 years.

Measurements: Self-reported incident colorectal adenocarcinoma confirmed by medical record review.

Results: 169 women developed colorectal adenocarcinomas during follow-up. Baseline CRP levels were not significantly associated with colorectal cancer risk. The multivariate hazard ratios according to cutoff points for CRP proposed in clinical guidelines were 0.79 (95% CI, 0.53 to 1.17) for the category of 1 to 3 mg/L and 0.66 (CI, 0.43 to 1.03) for the category of greater than 3 mg/L (P for trend = 0.09), as compared with the category of less than 1 mg/L. High CRP levels were also not associated with increased risk in analyses done according to tumor location and stage at diagnosis, according to alternative cutoff points for CRP, or in any of the subgroups evaluated.

Limitations: Despite multivariate analysis, residual confounding might still be present. Although this study was prospective, we cannot completely exclude undetected cancer at baseline. Measurements for CRP were available for only 71% of women in the cohort; however, the women who did and those who did not provide blood were mostly similar.

Conclusions: Plasma CRP levels do not appear to predict an increased risk for developing colorectal cancer in apparently healthy women. Low-grade inflammation may not play an important role in increasing the risk for colorectal cancer.

Editors' Notes Context Some data suggest that low-grade inflammation may play a role in the development of colorectal cancer. Contribution In this 10-year prospective study involving 27 913 healthy women age 45 years or older, elevated C-reactive protein (CRP) levels at baseline were not associated with a higher likelihood of colorectal cancer. Cautions A single baseline CRP measurement may be an imperfect marker of inflammation. The investigators relied on a woman's report of cancer rather than an ongoing surveillance protocol for colorectal lesions. Implications Low-grade inflammation may not be associated with in-creased colorectal cancer risk. –The Editors

 

Author and Article Information

From Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts.

Acknowledgments: The authors thank Marilyn Chown for her statistical analytic support, the staff of the Women's Health Study, and the 39 876 dedicated participants of the Women's Health Study.

Grant Support: By research grants CA-47988 and HL-43851 from the National Institutes of Health, with additional support from the Doris Duke Foundation and the Donald W. Reynolds Foundation. Dr. Zhang is supported in part by a National Cancer Institute Career Development Award (CA096619).

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Shumin M. Zhang, MD, ScD, Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215; e-mail, shumin.zhang{at}channing.harvard.edu.

Current Author Addresses: Drs. Zhang, Buring, Cook, Lee, and Ridker: Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215.

Author Contributions: Conception and design: S.M. Zhang, P.M. Ridker.

Analysis and interpretation of the data: S.M. Zhang, N.R. Cook, P.M. Ridker.

Drafting of the article: S.M. Zhang, P.M. Ridker.

Critical revision of the article for important intellectual content: S.M. Zhang, J.E. Buring, I.-M. Lee, N.R. Cook, P.M. Ridker.

Final approval of the article: S.M. Zhang, J.E. Buring, I.-M. Lee, N.R. Cook, P.M. Ridker.

Statistical expertise: S.M. Zhang, N.R. Cook, P.M. Ridker.

Obtaining of funding: J.E. Buring, P.M. Ridker.

Administrative, technical, or logistic support: S.M. Zhang, I.-M. Lee, P.M. Ridker.

Collection and assembly of data: S.M. Zhang, J.E. Buring, I.-M. Lee, P.M. Ridker.

Related articles in Annals:

Summaries for Patients
Can a Blood Test Help Predict Who Is at Risk for Colorectal Cancer?

Annals 2005 142: I-79. [Full Text]  

Letters
C-Reactive Protein and Risk for Colorectal Cancer
Luca Mascitelli AND Francesca Pezzetta

Annals 2005 143: 544. [Full Text]  

Letters
C-Reactive Protein and Risk for Colorectal Cancer
Shumin M. Zhang AND Paul M Ridker

Annals 2005 143: 544. [Full Text]  

This article has been cited by other articles:

				J. Lin, I-M. Lee, N. R Cook, J. Selhub, J. E Manson, J. E Buring, and S. M Zhang Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women Am. J. Clinical Nutrition, March 1, 2008; 87(3): 734 - 743. [Abstract] [Full Text] [PDF]

				S. Kim, T. O. Keku, C. Martin, J. Galanko, J. T. Woosley, J. C. Schroeder, J. A. Satia, S. Halabi, and R. S. Sandler Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas Cancer Res., January 1, 2008; 68(1): 323 - 328. [Abstract] [Full Text] [PDF]

				J. Lin, J. E. Manson, J. Selhub, J. E. Buring, and S. M. Zhang Plasma Cysteinylglycine Levels and Breast Cancer Risk in Women Cancer Res., December 1, 2007; 67(23): 11123 - 11127. [Abstract] [Full Text] [PDF]

				K. L. Margolis, R. J. Rodabough, C. A. Thomson, A. M. Lopez, A. McTiernan, and for the Women's Health Initiative Research Group Prospective Study of Leukocyte Count as a Predictor of Incident Breast, Colorectal, Endometrial, and Lung Cancer and Mortality in Postmenopausal Women Arch Intern Med, September 24, 2007; 167(17): 1837 - 1844. [Abstract] [Full Text] [PDF]

				K. Heikkila, S. Ebrahim, and D. A Lawlor A systematic review of the association between circulating concentrations of C reactive protein and cancer J. Epidemiol. Community Health, September 1, 2007; 61(9): 824 - 833. [Abstract] [Full Text] [PDF]

				S. M. Zhang, J. Lin, N. R. Cook, I-M. Lee, J. E. Manson, J. E. Buring, and P. M. Ridker C-Reactive Protein and Risk of Breast Cancer J Natl Cancer Inst, June 6, 2007; 99(11): 890 - 894. [Abstract] [Full Text] [PDF]

				N. A. Shadick, N. R. Cook, E. W. Karlson, P. M Ridker, N. E. Maher, J. E. Manson, J. E. Buring, and I.-M. Lee C-Reactive Protein in the Prediction of Rheumatoid Arthritis in Women Arch Intern Med, December 11, 2006; 166(22): 2490 - 2494. [Abstract] [Full Text] [PDF]

				C. Siemes, L. E. Visser, J.-W. W. Coebergh, T. A.W. Splinter, J. C.M. Witteman, A. G. Uitterlinden, A. Hofman, H. A.P. Pols, and B. H.Ch. Stricker C-Reactive Protein Levels, Variation in the C-Reactive Protein Gene, and Cancer Risk: The Rotterdam Study J. Clin. Oncol., November 20, 2006; 24(33): 5216 - 5222. [Abstract] [Full Text] [PDF]

				P. Libby and P. M. Ridker Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A33 - A46. [Abstract] [Full Text] [PDF]

				D. Mazhar and S. Ngan C-reactive protein and colorectal cancer. QJM, August 1, 2006; 99(8): 555 - 559. [Full Text] [PDF]

				T. Otani, M. Iwasaki, S. Sasazuki, M. Inoue, S. Tsugane, and Japan Public Health Center-Based Prospective Study Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan public health center-based prospective study. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 690 - 695. [Abstract] [Full Text] [PDF]

				M. J. Gunter, R. Stolzenberg-Solomon, A. J. Cross, M. F. Leitzmann, S. Weinstein, R. J. Wood, J. Virtamo, P. R. Taylor, D. Albanes, and R. Sinha A Prospective Study of Serum C-Reactive Protein and Colorectal Cancer Risk in Men Cancer Res., February 15, 2006; 66(4): 2483 - 2487. [Abstract] [Full Text] [PDF]

				D. Trichopoulos, T. Psaltopoulou, P. Orfanos, A. Trichopoulou, and P. Boffetta Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 381 - 384. [Abstract] [Full Text] [PDF]

				A. Shankar, J. J. Wang, E. Rochtchina, M. C. Yu, R. Kefford, and P. Mitchell Association Between Circulating White Blood Cell Count and Cancer Mortality: A Population-Based Cohort Study Arch Intern Med, January 23, 2006; 166(2): 188 - 194. [Abstract] [Full Text] [PDF]

				L. Mascitelli and F. Pezzetta C-Reactive Protein and Risk for Colorectal Cancer Ann Intern Med, October 4, 2005; 143(7): 544 - 544. [Full Text] [PDF]

				D. Il'yasova, L. H. Colbert, T. B. Harris, A. B. Newman, D. C. Bauer, S. Satterfield, and S. B. Kritchevsky Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition Cohort Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2413 - 2418. [Abstract] [Full Text] [PDF]

				C-Reactive Protein Is Not Associated with Colorectal Cancer in Women Journal Watch Gastroenterology, March 29, 2005; 2005(329): 3 - 3. [Full Text]

				A. Tonks What's new in the other general journals BMJ, March 26, 2005; 330(7493): 693 - 694. [Full Text] [PDF]

Rapid Responses: